#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13276	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2159	611.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	845	C	753	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13276	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2159	611.8	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1664	1664	T	759	TGGGGG,TGGGGGG	501,158	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	0	.	n	.	0	A20C	SNP	20	20	A	465	465	C	472	C,A	280,159	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	0	.	n	.	0	T695C	SNP	695	695	T	1140	1140	C	686	C,T	626,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2083	2083	G	764	G	699	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2416	2416	C	827	C,G	750,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2490	2490	A	819	A	752	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23296	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3620	641.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3042	3042	C	754	C	683	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1918	folP	855	855	100.0	folP.l6.c4.ctg.1	1558	122.5	1	SNP	p	R229S	1	.	.	685	687	AGC	986	988	AGC	198;197;199	A;G;C	184;182;182	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3252	167.5	1	SNP	p	S91F	1	.	.	271	273	TTC	476	478	TTC	188;189;190	T;T;C	173;172;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3252	167.5	1	SNP	p	G95N	0	.	.	283	285	GGC	488	490	GGC	189;192;189	G;G;C	169;175;170	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3252	167.5	1	SNP	p	D95G	1	.	.	283	285	GGC	488	490	GGC	189;192;189	G;G;C	169;175;170	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1646	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1292	127.0	0	.	p	.	0	F184L	NONSYN	550	552	TTC	907	909	TTG	197;195;196	T;T;G	177;173;174	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1646	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1292	127.0	1	SNP	p	G45D	0	.	.	133	135	GGC	490	492	GGC	219;217;216	G;G;C	200;195;197	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	718	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	816	87.4	0	.	n	.	0	A197.	DEL	197	197	A	459	459	A	191	A	162	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	171.4	1	SNP	p	D86N	0	.	.	256	258	GAC	563	565	GAC	198;199;198	G,A;A;C	178,1;182;182	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	171.4	1	SNP	p	R87W	0	.	.	259	261	CGT	566	568	CGT	197;196;196	C;G;T	183;178;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	171.4	1	SNP	p	S87R	1	.	.	259	261	CGT	566	568	CGT	197;196;196	C;G;T	183;178;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	171.4	1	SNP	p	R87I	0	.	.	259	261	CGT	566	568	CGT	197;196;196	C;G;T	183;178;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	171.4	1	SNP	p	S88P	0	.	.	262	264	TCC	569	571	TCC	195;196;192	T;C;C	180;179;174	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4204	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2504	167.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	213;208;209	G;G;C	188;179;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1259	1261	GCA	209;210;213	G;C;A	185;184;188	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1262	1264	ATC	214;215;216	A;T;C	189;189;187	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1274	1276	GTG	219;220;220	G;T;G	194;193;194	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1274	1276	GTG	219;220;220	G;T;G	194;193;194	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1778	1780	ACC	185;187;189	A;C;C	161;169;168	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1832	1834	GCG	196;195;193	G;C;G,A	167;154;156,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1832	1834	GCG	196;195;193	G;C;G,A	167;154;156,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1955	1957	AGC	165;163;162	A;G;C	148;147;146	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1964	1966	GGC	160;156;157	G;G;C	145;138;140	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3786	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2380	158.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1982	1984	CCG	151;154;155	C,G;C,G;G	98,9;104,1;102	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5266	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3115	168.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1700	1702	CCG	213;210;207	C;C;G	191;194;188	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2202	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1875	117.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	147	C	133	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	97	99	TTA	60;67;67	T,G;T;A	50,2;58;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	142	144	CAT	69;69;64	C,G;A;T	64,1;65;61	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	145	147	AGT	65;68;68	A;G;T	60;62;62	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	154	156	TAC	68;68;68	T;A;C	62;61;61	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	R307A	NONSYN	919	921	AGA	244	246	GCA	20;19;16	G;C;A	20;19;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	256	258	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	259	261	GAC	15;14;13	G;A;C	15;14;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	265	267	ATC	12;11;11	A;T;C	12;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	271	273	TCG	11;11;11	T,C;C;G	9,1;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	277	279	GCC	12;13;13	G;C;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	280	282	AGC	13;13;13	A;G;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	283	285	GCC	13;13;12	G;C;C	11;13;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	326	38.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	289	291	GTT	11;10;10	G;T;T	10;10;10	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	356	358	GAA	241;245;243	G;A;A	213;218;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	767	769	TCA	204;203;204	T;C;A	186;187;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	896	898	GTC	221;219;216	G;T;C	210;203;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	908	910	TCT	223;223;223	T;C,T;T	210;211,1;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1226	1228	GCA	230;225;218	G;C,T;A	208;203,1;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	1	SNP	p	G120K	1	.	.	358	360	AAG	602	604	AAG	202;204;204	A;A;G	180;182;181	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	1	SNP	p	A121D	1	.	.	361	363	GAC	605	607	GAC	205;202;204	G;A;C	182;180;181	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2670	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1430	185.3	1	SNP	p	D121N	0	.	.	361	363	GAC	605	607	GAC	205;202;204	G;A;C	182;180;181	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9868	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4758	206.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1074	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1118	95.5	1	SNP	p	V57M	1	.	.	169	171	ATG	617	619	ATG	218;223;228	A,G;T;G	201,1;206;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
